SentryX is thrilled to have been awarded €15.5 million in funding from the EIC Accelerator program, advancing its mission to drastically improve recovery after musculoskeletal surgery and make healthcare more affordable.

The funds will be used to accelerate the clinical development of BR-003: an innovative long-acting co-implantable anesthetic that will be applied in spinal fusion surgery before expanding to other musculoskeletal procedures. Stay tuned for updates on the first clinical trial, which will commence soon.

Many thanks to the EIC and everyone who helped on the proposal, especially team IRIS with the RvO who provided invaluable guidance and support throughout. Also, congratulations to the six (!) other Dutch startups who were successful in this round.